Arno Therapeutics Inc. (ARNI) OTC MARKETS
$0 - (-)
Market Cap: $14805
As of 04/23/24 12:00 AM EDT. Market open.
Arno Therapeutics Inc. (ARNI)
OTC MARKETS
$0
- (-)
Market Cap: $14805
As of 04/23/24 12:00 AM EDT. Market open.
Add to Portfolio
arno therapeutics inc (arni) is a pharmaceuticals company located in 4 campus drive, 2nd floor, parsippany, nj, united ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Alexander Zukiwski
Full Time Employees
4
URL
Address
200 State Route 31 Ste 104, New Jersey, Flemington, 08822-5812.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Alexander Zukiwski
Full Time Employees
4
URL
Address
200 State Route 31 Ste 104, New Jersey, Flemington, 08822-5812.
PRICE CHART FOR ARNO THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0
Days Range
- - -
52 week range
$0 - $0
Volume
3,500
Avg. Volume (30 days)
3,500
Market Cap
$14805
Dividend Yield
-
P/E
-
Shares Outstanding
49,349,749
Open
-
Previous Close
$0
Days Range
- - -
52 week range
$0 - $0
Volume
3,500
Avg. Volume (30 days)
3,500
Market Cap
$14805
Dividend Yield
-
P/E
-
Shares Outstanding
49,349,749
FINANCIAL STATEMENTS FOR ARNO THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR ARNO THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Kariv Tomer | Director | Jan 12, 2016 | Buy | $0.35 | 206,986 | 72,445 | 393,968 | Apr 11, 2016, 04:22 PM |
Kariv Tomer | Director | Jan 12, 2016 | Buy | $0.35 | 533,208 | 186,623 | 1,014,888 | Apr 11, 2016, 04:22 PM |
Kariv Tomer | Director | Jan 12, 2016 | Buy | $0.35 | 707,868 | 247,754 | 1,347,327 | Apr 11, 2016, 04:22 PM |
Ruchefsky Steven B | Director | Jan 12, 2016 | Buy | $0.35 | 2,876,633 | 1,006,822 | 4,472,905 | Jan 14, 2016, 05:20 PM |
Zukiwski Alexander A | VP & Chief Medical Officer | Jan 12, 2016 | Buy | $0.35 | 144,806 | 50,682 | 261,832 | Jan 14, 2016, 05:20 PM |
TANEN DAVID M | Secretary | Jan 12, 2016 | Buy | $0.35 | 362,015 | 126,705 | 362,015 | Jan 14, 2016, 05:20 PM |
Belldegrun Arie | Director | Jan 12, 2016 | Buy | $0.35 | 714,285 | 250,000 | 858,094 | Jan 14, 2016, 05:19 PM |
Belldegrun Arie | Director | Jan 12, 2016 | Buy | $0.35 | 1,448,062 | 506,822 | 1,548,543 | Jan 14, 2016, 05:19 PM |
Kariv Tomer | Director | Jan 12, 2016 | Buy | $0.35 | 206,986 | 72,445 | 393,968 | Jan 14, 2016, 05:19 PM |
Kariv Tomer | Director | Jan 12, 2016 | Buy | $0.35 | 533,208 | 186,623 | 1,014,888 | Jan 14, 2016, 05:19 PM |
Kariv Tomer | Director | Jan 12, 2016 | Buy | $0.35 | 707,868 | 247,754 | 1,347,327 | Jan 14, 2016, 05:19 PM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 6,666 | 15,998 | 100,481 | Nov 05, 2013, 10:08 AM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 5,000 | 12,000 | 91,312 | Nov 05, 2013, 10:08 AM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 66,652 | 159,965 | 86,312 | Nov 05, 2013, 10:08 AM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 88,871 | 213,290 | 93,815 | Nov 05, 2013, 10:08 AM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 11,666 | 27,998 | 191,794 | Nov 05, 2013, 10:08 AM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 10,000 | 24,000 | 150,721 | Nov 05, 2013, 10:08 AM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 155,523 | 373,255 | 180,128 | Nov 05, 2013, 10:08 AM |
Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 133,305 | 319,932 | 140,721 | Nov 05, 2013, 10:08 AM |
Zukiwski Alexander A | VP & Chief Medical Officer | Oct 29, 2013 | Option Exercise | $2.40 | 5,000 | 12,000 | 75,360 | Oct 31, 2013, 07:53 PM |
Zukiwski Alexander A | VP & Chief Medical Officer | Oct 29, 2013 | Option Exercise | $2.40 | 66,652 | 159,965 | 70,360 | Oct 31, 2013, 07:53 PM |
Proniuk Stefan | VP of Product Development | Oct 29, 2013 | Option Exercise | $2.40 | 666 | 1,598 | 10,047 | Oct 31, 2013, 07:40 PM |
Proniuk Stefan | VP of Product Development | Oct 29, 2013 | Option Exercise | $2.40 | 8,887 | 21,329 | 9,381 | Oct 31, 2013, 07:40 PM |
Ruchefsky Steven B | Director | Oct 29, 2013 | Option Exercise | $2.40 | 41,666 | 99,998 | 1,596,272 | Oct 31, 2013, 07:38 PM |
Ruchefsky Steven B | Director | Oct 29, 2013 | Option Exercise | $2.40 | 555,440 | 1,333,056 | 867,106 | Oct 31, 2013, 07:38 PM |
Mattes Glenn R. | President & CEO | Oct 29, 2013 | Option Exercise | $2.40 | 1,666 | 3,998 | 56,370 | Oct 31, 2013, 07:36 PM |
Mattes Glenn R. | President & CEO | Oct 29, 2013 | Option Exercise | $2.40 | 22,218 | 53,323 | 54,704 | Oct 31, 2013, 07:36 PM |
Kariv Tomer | Director | Oct 29, 2013 | Option Exercise | $2.40 | 4,764 | 11,434 | 127,424 | Oct 31, 2013, 07:33 PM |
Kariv Tomer | Director | Oct 29, 2013 | Option Exercise | $2.40 | 12,274 | 29,458 | 328,254 | Oct 31, 2013, 07:33 PM |
Kariv Tomer | Director | Oct 29, 2013 | Option Exercise | $2.40 | 16,294 | 39,106 | 435,777 | Oct 31, 2013, 07:33 PM |
Kariv Tomer | Director | Oct 29, 2013 | Option Exercise | $2.40 | 63,516 | 152,438 | 122,660 | Oct 31, 2013, 07:33 PM |
Kariv Tomer | Director | Oct 29, 2013 | Option Exercise | $2.40 | 163,620 | 392,688 | 315,980 | Oct 31, 2013, 07:33 PM |
Kariv Tomer | Director | Oct 29, 2013 | Option Exercise | $2.40 | 217,216 | 521,318 | 419,483 | Oct 31, 2013, 07:33 PM |
WEXFORD CAPITAL LP | No longer own 10% of Issuer | Oct 04, 2013 | Sale | $0.48 | 325 | 156 | 2,827,844 | Oct 09, 2013, 05:31 PM |
Kariv Tomer | Director | May 28, 2013 | Option Exercise | $0.30 | 9,529 | 2,859 | 473,156 | Jun 05, 2013, 04:05 PM |
Kariv Tomer | Director | May 28, 2013 | Option Exercise | $0.30 | 24,548 | 7,364 | 1,218,883 | Jun 05, 2013, 04:05 PM |
Kariv Tomer | Director | May 28, 2013 | Option Exercise | $0.30 | 32,589 | 9,777 | 1,618,140 | Jun 05, 2013, 04:05 PM |
Ruchefsky Steven B | Director | May 28, 2013 | Option Exercise | $0.30 | 80,556 | 24,167 | 2,493,331 | Jun 04, 2013, 04:16 PM |
Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 22,556 | 6,767 | 196,841 | Jun 03, 2013, 04:46 PM |
Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 19,333 | 5,800 | 59,333 | Jun 03, 2013, 04:46 PM |
Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 12,889 | 3,867 | 39,555 | Jun 03, 2013, 04:46 PM |
Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 9,667 | 2,900 | 157,286 | Jun 03, 2013, 04:46 PM |
Zukiwski Alexander A | VP & Chief Medical Officer | May 28, 2013 | Option Exercise | $0.30 | 9,667 | 2,900 | 29,667 | May 30, 2013, 05:05 PM |
Proniuk Stefan | VP of Product Development | May 28, 2013 | Option Exercise | $0.30 | 1,289 | 387 | 3,955 | May 30, 2013, 05:04 PM |
Mattes Glenn R. | President & CEO | May 28, 2013 | Option Exercise | $0.30 | 3,222 | 967 | 259,888 | May 30, 2013, 05:02 PM |
THURMAN RANDY H | Director | May 22, 2013 | Buy | $0.50 | 2,500 | 1,250 | 10,000 | May 23, 2013, 04:57 PM |
THURMAN RANDY H | Director | May 21, 2013 | Buy | $0.50 | 7,500 | 3,750 | 7,500 | May 23, 2013, 04:57 PM |
Ruchefsky Steven B | Director | Apr 29, 2013 | Option Exercise | $0.30 | 83,333 | 25,000 | 2,412,775 | May 07, 2013, 01:05 PM |
Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 13,333 | 4,000 | 26,666 | May 07, 2013, 12:20 PM |
Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 10,000 | 3,000 | 147,619 | May 07, 2013, 12:20 PM |
Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 23,333 | 7,000 | 174,285 | May 07, 2013, 12:20 PM |
Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 20,000 | 6,000 | 40,000 | May 07, 2013, 12:20 PM |
Mattes Glenn R. | President & CEO | Apr 29, 2013 | Option Exercise | $0.30 | 3,333 | 1,000 | 256,666 | May 07, 2013, 10:12 AM |
Zukiwski Alexander A | VP & Chief Medical Officer | Apr 29, 2013 | Option Exercise | $0.30 | 10,000 | 3,000 | 20,000 | May 07, 2013, 09:15 AM |
Kariv Tomer | Director | Apr 29, 2013 | Option Exercise | $0.30 | 16,291 | 4,887 | 463,627 | May 07, 2013, 09:14 AM |
Kariv Tomer | Director | Apr 29, 2013 | Option Exercise | $0.30 | 41,967 | 12,590 | 1,194,335 | May 07, 2013, 09:14 AM |
Kariv Tomer | Director | Apr 29, 2013 | Option Exercise | $0.30 | 55,714 | 16,714 | 1,585,551 | May 07, 2013, 09:14 AM |
Proniuk Stefan | VP of Product Development | Apr 29, 2013 | Option Exercise | $0.30 | 1,333 | 400 | 2,666 | May 06, 2013, 05:10 PM |
Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 23,333 | 7,000 | 150,952 | Apr 15, 2013, 09:32 AM |
Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 20,000 | 6,000 | 20,000 | Apr 15, 2013, 09:32 AM |
Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 13,333 | 4,000 | 13,333 | Apr 15, 2013, 09:32 AM |
Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 10,000 | 3,000 | 137,619 | Apr 15, 2013, 09:32 AM |
Zukiwski Alexander A | VP & Chief Medical Officer | Mar 27, 2013 | Option Exercise | $0.30 | 10,000 | 3,000 | 10,000 | Apr 11, 2013, 02:01 PM |
Proniuk Stefan | VP of Product Development | Mar 27, 2013 | Option Exercise | $0.30 | 1,333 | 400 | 1,333 | Apr 10, 2013, 10:30 AM |
Kariv Tomer | Director | Mar 27, 2013 | Option Exercise | $0.30 | 9,529 | 2,859 | 447,336 | Apr 10, 2013, 09:51 AM |
Kariv Tomer | Director | Mar 27, 2013 | Option Exercise | $0.30 | 24,548 | 7,364 | 1,152,368 | Apr 10, 2013, 09:51 AM |
Kariv Tomer | Director | Mar 27, 2013 | Option Exercise | $0.30 | 32,589 | 9,777 | 1,529,837 | Apr 10, 2013, 09:51 AM |
Ruchefsky Steven B | Director | Mar 27, 2013 | Option Exercise | $0.30 | 83,333 | 25,000 | 2,329,442 | Apr 09, 2013, 05:46 PM |
Mattes Glenn R. | President & CEO | Mar 27, 2013 | Option Exercise | $0.30 | 3,333 | 1,000 | 253,333 | Apr 09, 2013, 05:40 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Kariv Tomer | Director | 01/12/2016 | 72,445 |
Kariv Tomer | Director | 01/12/2016 | 186,623 |
Kariv Tomer | Director | 01/12/2016 | 247,754 |
Ruchefsky Steven B | Director | 01/12/2016 | 1,006,822 |
Zukiwski Alexander A | VP & Chief Medical Officer | 01/12/2016 | 50,682 |
TANEN DAVID M | Secretary | 01/12/2016 | 126,705 |
Belldegrun Arie | Director | 01/12/2016 | 250,000 |
Belldegrun Arie | Director | 01/12/2016 | 506,822 |
Kariv Tomer | Director | 01/12/2016 | 72,445 |
Kariv Tomer | Director | 01/12/2016 | 186,623 |
Kariv Tomer | Director | 01/12/2016 | 247,754 |
Belldegrun Arie | Director | 10/29/2013 | 15,998 |
Belldegrun Arie | Director | 10/29/2013 | 12,000 |
Belldegrun Arie | Director | 10/29/2013 | 159,965 |
Belldegrun Arie | Director | 10/29/2013 | 213,290 |
Belldegrun Arie | Director | 10/29/2013 | 27,998 |
Belldegrun Arie | Director | 10/29/2013 | 24,000 |
Belldegrun Arie | Director | 10/29/2013 | 373,255 |
Belldegrun Arie | Director | 10/29/2013 | 319,932 |
Zukiwski Alexander A | VP & Chief Medical Officer | 10/29/2013 | 12,000 |
Zukiwski Alexander A | VP & Chief Medical Officer | 10/29/2013 | 159,965 |
Proniuk Stefan | VP of Product Development | 10/29/2013 | 1,598 |
Proniuk Stefan | VP of Product Development | 10/29/2013 | 21,329 |
Ruchefsky Steven B | Director | 10/29/2013 | 99,998 |
Ruchefsky Steven B | Director | 10/29/2013 | 1,333,056 |
Mattes Glenn R. | President & CEO | 10/29/2013 | 3,998 |
Mattes Glenn R. | President & CEO | 10/29/2013 | 53,323 |
Kariv Tomer | Director | 10/29/2013 | 11,434 |
Kariv Tomer | Director | 10/29/2013 | 29,458 |
Kariv Tomer | Director | 10/29/2013 | 39,106 |
Kariv Tomer | Director | 10/29/2013 | 152,438 |
Kariv Tomer | Director | 10/29/2013 | 392,688 |
Kariv Tomer | Director | 10/29/2013 | 521,318 |
WEXFORD CAPITAL LP | No longer own 10% of Issuer | 10/04/2013 | 156 |
Kariv Tomer | Director | 05/28/2013 | 2,859 |
Kariv Tomer | Director | 05/28/2013 | 7,364 |
Kariv Tomer | Director | 05/28/2013 | 9,777 |
Ruchefsky Steven B | Director | 05/28/2013 | 24,167 |
Belldegrun Arie | Director | 05/28/2013 | 6,767 |
Belldegrun Arie | Director | 05/28/2013 | 5,800 |
Belldegrun Arie | Director | 05/28/2013 | 3,867 |
Belldegrun Arie | Director | 05/28/2013 | 2,900 |
Zukiwski Alexander A | VP & Chief Medical Officer | 05/28/2013 | 2,900 |
Proniuk Stefan | VP of Product Development | 05/28/2013 | 387 |
Mattes Glenn R. | President & CEO | 05/28/2013 | 967 |
THURMAN RANDY H | Director | 05/22/2013 | 1,250 |
THURMAN RANDY H | Director | 05/21/2013 | 3,750 |
Ruchefsky Steven B | Director | 04/29/2013 | 25,000 |
Belldegrun Arie | Director | 04/29/2013 | 4,000 |
Belldegrun Arie | Director | 04/29/2013 | 3,000 |
Belldegrun Arie | Director | 04/29/2013 | 7,000 |
Belldegrun Arie | Director | 04/29/2013 | 6,000 |
Mattes Glenn R. | President & CEO | 04/29/2013 | 1,000 |
Zukiwski Alexander A | VP & Chief Medical Officer | 04/29/2013 | 3,000 |
Kariv Tomer | Director | 04/29/2013 | 4,887 |
Kariv Tomer | Director | 04/29/2013 | 12,590 |
Kariv Tomer | Director | 04/29/2013 | 16,714 |
Proniuk Stefan | VP of Product Development | 04/29/2013 | 400 |
Belldegrun Arie | Director | 03/27/2013 | 7,000 |
Belldegrun Arie | Director | 03/27/2013 | 6,000 |
Belldegrun Arie | Director | 03/27/2013 | 4,000 |
Belldegrun Arie | Director | 03/27/2013 | 3,000 |
Zukiwski Alexander A | VP & Chief Medical Officer | 03/27/2013 | 3,000 |
Proniuk Stefan | VP of Product Development | 03/27/2013 | 400 |
Kariv Tomer | Director | 03/27/2013 | 2,859 |
Kariv Tomer | Director | 03/27/2013 | 7,364 |
Kariv Tomer | Director | 03/27/2013 | 9,777 |
Ruchefsky Steven B | Director | 03/27/2013 | 25,000 |
Mattes Glenn R. | President & CEO | 03/27/2013 | 1,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ARNO THERAPEUTICS INC
LOADING...